Concepedia
Statistics
Publications
46
Citations
5.9K
H-Index
32
Active since
1992
Affiliations
Novartis (Switzerland)(Current)
Novartis (United Kingdom)
Novartis (United States)
Novartis (Italy)
Ghent University Hospital
Giovanni Della Cioppa is an author at Novartis (Switzerland) specializing in immunology, pharmacy, and pharmacotherapy.
Publications per year
1992–2022
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text
Life Sciences, Immunology, Pharmacology +16
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M. Solèr, Jonathan Matz, Robert G. Townley et al. · European Respiratory Journal · 2001 · 826 citations · Full text
Life Sciences, Pharmacology, Pharmacotherapy +17
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
Stephen T. Holgate, Jean‐Louis Hébert, Jan Lötvall et al. · Clinical & Experimental Allergy · 2004 · 520 citations
Pharmacy, Pharmacology, Pharmacotherapy +16
Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease
Ronald Dahl, Louis A.P.M. Greefhorst, Dariusz Nowak et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 353 citations
Pharmacy, Pharmacotherapy, Pulmonary Function Testing +16
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
Steven Black, Uwe Nicolay, Timo Vesikari et al. · The Pediatric Infectious Disease Journal · 2011 · 337 citations
Veterinary Medicine, Immunology, Infectious Diseases +17
1–5 of 46